Exclusive

Publication

Byline

Location

Gujarat CM Bhupendra Patel visits BAPS Akshardham temple in New Jersey

New Jersey, Aug. 23 -- Gujarat Chief Minister Bhupendra Patel, on the seventh day of his US visit, visited BAPS (Bochasanwasi Akshar Purushottam Swaminarayan Sanstha) Swaminarayan Akshardham temple in... Read More


It was the multidimensional tragedy that I wished to portray: Mitra Phukan

New Delhi, Aug. 23 -- Conflict, in its many forms, is at the core of the fiction of Mitra Phukan, the award-winning Assamese writer, translator, and columnist. A trained Shastriya Sangeet vocalist, sh... Read More


డయల్ 112 పోలీసు, అగ్నిమాపక, అంబులెన్స్ సేవలతో అనుసంధానం

భారతదేశం, ఆగస్టు 23 -- డయల్ 112 ఎమర్జెన్సీ సేవలను మూడు విభాగాలతో కలపనున్నారు. ఆంధ్రప్రదేశ్ విపత్తు నిర్వహణ, అగ్నిమాపక సేవల విభాగం డైరెక్టర్ జనరల్ పి.వెంకట రమణ ఈ విషయాన్ని వెల్లడించారు. డయల్ 112 అత్యవస... Read More


Singapore Clinical Trial: Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations

Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant... Read More


Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the ef... Read More


Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigat... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More


Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, Aug. 23 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More


जहर खाने से नहीं गर्भपात के दौरान हुए रक्तस्राव से हुई थी किशोरी की मौत, दाई हिरासत में

बस्ती, अगस्त 23 -- बस्ती, हिन्दुस्तान टीम। हर्रैया थाना क्षेत्र के एक गांव की किशोरी और किशोर के मौत मामले की कहानी में बदलाव आ गया है। किशोरी की मौत गर्भपात के दौरान हुए काफी रक्तस्राव से हो गई थी। म... Read More